BIOL logo

BIOLASE (BIOL) Revenue

Annual Revenue

$49.16 M
+$702.00 K+1.45%

December 31, 2023

Summary

Performance

1-Year Change

+1.45%

3-Year Change

+115.82%

5-Year Change

+6.52%

15-Year Change

+4.77%

BIOL Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$49.50 M
BIOL annual revenue is currently -0.68% lower than the consensus analysts' forecast

High & Low

All-time High

$69.70 M
BIOL annual revenue is currently -29.46% below its historical high of $69.70 million

3-Year Low

$39.19 M
BIOL annual revenue is currently +25.46% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BIOL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
BIOL next annual earnings announcement has not yet been scheduled

OtherBIOLprofitabilitymetrics:

Annual EPS

-$29.44
BIOL annual earnings per share is -$29.44

Annual Net Income

-$20.63 M
BIOL annual net profit is -$20.63 million

Annual Operating Profit

-$17.94 M
BIOL annual operating income is -$17.94 million

Annual Gross Profit

$16.72 M
BIOL annual gross profit is $16.72 million

Quarterly Revenue

$10.85 M
-$705.00 K-6.10%

September 30, 2024

Summary

Performance

3-Month Change

-6.1%

1-Year Change

-0.65%

3-Year Change

-0.65%

5-Year Change

-0.65%

BIOL Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$15.50 M
BIOL quarterly revenue is currently -30.00% lower than the consensus analysts' forecast

High & Low

All-time High

$20.84 M
BIOL quarterly revenue is currently -47.94% below its historical high of $20.84 million

3-Year Low

$10.13 M
BIOL quarterly revenue is currently +7.10% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BIOL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
BIOL next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$4.38 M
BIOL quarterly gross profit is $4.38 million

Quarterly Operating Profit

-$695.00 K
BIOL quarterly operating income is -$695.00 thousand

Quarterly Net Income

-$1.43 M
BIOL quarterly net profit is -$1.43 million

Quarterly EPS

-$0.04
BIOL quarterly earnings per share is -$0.04

TTM Revenue

$46.03 M
-$71.00 K-0.15%

September 30, 2024

Summary

Performance

3-Month Change

-0.15%

1-Year Change

-7.44%

3-Year Change

-7.44%

5-Year Change

-7.44%

BIOL TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$48.04 M
BIOL TTM revenue is currently -4.18% lower than the consensus analysts' forecast

High & Low

All-time High

$73.83 M
BIOL TTM revenue is currently -37.66% below its historical high of $73.83 million

3-Year Low

$39.19 M
BIOL TTM revenue is currently +17.45% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BIOL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
BIOL next earnings announcement has not yet been scheduled

OtherBIOLprofitabilitymetrics:

TTM Gross Profit

$15.85 M
BIOL TTM gross profit is $15.85 million

TTM Operating Profit

-$13.52 M
BIOL TTM operating income is -$13.52 million

TTM Net Income

-$16.04 M
BIOL TTM net profit is -$16.04 million

TTM EPS

-$7.01
BIOL TTM earnings per share is -$7.01

BIOL Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1.4%-0.7%-7.4%
3 y3 years+115.8%-0.7%-7.4%
5 y5 years+6.5%-0.7%-7.4%

BIOL Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-20.3%-24.1%-6.6%-9.4%-14.9%
5 y5-yearat high-53.7%-24.1%-72.9%-9.4%-50.5%
alltimeall time-29.5%-98.6%-47.9%-99.1%-37.7%-98.7%

BIOLASE Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$10.85 M(-6.1%)
$46.03 M(-0.2%)
Jun 2024
-
$11.55 M(+14.1%)
$46.10 M(-5.6%)
Mar 2024
-
$10.13 M(-24.9%)
$48.83 M(-0.7%)
Dec 2023
$49.16 M(+1.4%)
$13.49 M(+23.5%)
$49.16 M(-1.1%)
Sep 2023
-
$10.92 M(-23.6%)
$49.73 M(-2.1%)
Jun 2023
-
$14.29 M(+36.5%)
$50.81 M(+4.2%)
Mar 2023
-
$10.47 M(-25.5%)
$48.76 M(+0.6%)
Dec 2022
$48.46 M(+23.7%)
$14.05 M(+17.0%)
$48.46 M(+3.5%)
Sep 2022
-
$12.01 M(-1.8%)
$46.82 M(+5.6%)
Jun 2022
-
$12.23 M(+20.4%)
$44.34 M(+7.5%)
Mar 2022
-
$10.17 M(-18.1%)
$41.24 M(+5.2%)
Dec 2021
$39.19 M(+72.0%)
$12.41 M(+30.2%)
$39.19 M(+11.0%)
Sep 2021
-
$9.53 M(+4.3%)
$35.30 M(+9.3%)
Jun 2021
-
$9.13 M(+12.5%)
$32.31 M(+23.7%)
Mar 2021
-
$8.12 M(-4.7%)
$26.11 M(+14.6%)
Dec 2020
$22.78 M(-39.7%)
$8.52 M(+30.3%)
$22.78 M(-6.8%)
Sep 2020
-
$6.54 M(+122.6%)
$24.44 M(-7.9%)
Jun 2020
-
$2.94 M(-38.6%)
$26.55 M(-17.7%)
Mar 2020
-
$4.78 M(-53.0%)
$32.26 M(-14.7%)
Dec 2019
$37.80 M(-18.1%)
$10.18 M(+17.8%)
$37.80 M(-7.0%)
Sep 2019
-
$8.65 M(+0.0%)
$40.66 M(-5.3%)
Jun 2019
-
$8.64 M(-16.3%)
$42.95 M(-7.6%)
Mar 2019
-
$10.33 M(-20.8%)
$46.46 M(+0.7%)
Dec 2018
$46.16 M(-1.6%)
$13.04 M(+19.3%)
$46.16 M(+0.9%)
Sep 2018
-
$10.94 M(-10.0%)
$45.74 M(+0.3%)
Jun 2018
-
$12.15 M(+21.3%)
$45.61 M(-1.0%)
Mar 2018
-
$10.02 M(-20.7%)
$46.07 M(-1.8%)
Dec 2017
$46.93 M(-9.4%)
$12.63 M(+16.9%)
$46.93 M(-2.3%)
Sep 2017
-
$10.81 M(-14.3%)
$48.05 M(-4.8%)
Jun 2017
-
$12.61 M(+16.0%)
$50.48 M(-2.3%)
Mar 2017
-
$10.87 M(-21.0%)
$51.67 M(-0.3%)
Dec 2016
$51.81 M(+6.9%)
$13.76 M(+4.0%)
$51.81 M(-1.4%)
Sep 2016
-
$13.23 M(-4.2%)
$52.57 M(+3.9%)
Jun 2016
-
$13.81 M(+25.4%)
$50.57 M(+4.0%)
Mar 2016
-
$11.01 M(-24.2%)
$48.63 M(+0.3%)
Dec 2015
$48.48 M(+1.7%)
$14.52 M(+29.2%)
$48.48 M(+2.7%)
Sep 2015
-
$11.23 M(-5.4%)
$47.20 M(-3.0%)
Jun 2015
-
$11.87 M(+9.3%)
$48.68 M(+3.6%)
Mar 2015
-
$10.86 M(-18.0%)
$46.99 M(-1.4%)
Dec 2014
$47.66 M(-15.5%)
$13.24 M(+4.1%)
$47.66 M(-4.0%)
Sep 2014
-
$12.71 M(+24.8%)
$49.66 M(+0.7%)
Jun 2014
-
$10.19 M(-11.6%)
$49.29 M(-7.6%)
Mar 2014
-
$11.52 M(-24.4%)
$53.35 M(-5.5%)
Dec 2013
$56.43 M(-1.6%)
$15.24 M(+23.5%)
$56.43 M(-6.4%)
Sep 2013
-
$12.35 M(-13.4%)
$60.27 M(-2.3%)
Jun 2013
-
$14.25 M(-2.4%)
$61.70 M(+3.5%)
Mar 2013
-
$14.60 M(-23.5%)
$59.63 M(+4.0%)
Dec 2012
$57.36 M(+17.4%)
$19.08 M(+38.5%)
$57.36 M(+11.5%)
Sep 2012
-
$13.78 M(+13.2%)
$51.43 M(+1.4%)
Jun 2012
-
$12.18 M(-1.2%)
$50.71 M(+0.2%)
Mar 2012
-
$12.32 M(-6.4%)
$50.62 M(+3.6%)
Dec 2011
$48.86 M(+86.3%)
$13.16 M(+0.7%)
$48.86 M(+7.6%)
Sep 2011
-
$13.06 M(+8.1%)
$45.42 M(+17.7%)
Jun 2011
-
$12.08 M(+14.4%)
$38.58 M(+19.1%)
Mar 2011
-
$10.56 M(+8.7%)
$32.39 M(+23.5%)
Dec 2010
$26.23 M(-39.5%)
$9.72 M(+56.2%)
$26.23 M(-2.4%)
Sep 2010
-
$6.22 M(+5.6%)
$26.86 M(-17.9%)
Jun 2010
-
$5.89 M(+34.1%)
$32.72 M(-20.5%)
Mar 2010
-
$4.39 M(-57.5%)
$41.15 M(-5.1%)
Dec 2009
$43.35 M(-32.9%)
$10.35 M(-14.3%)
$43.35 M(-2.9%)
Sep 2009
-
$12.09 M(-15.6%)
$44.63 M(-6.7%)
Jun 2009
-
$14.32 M(+117.1%)
$47.83 M(-8.3%)
Mar 2009
-
$6.59 M(-43.3%)
$52.18 M(-19.3%)
Dec 2008
$64.63 M
$11.63 M(-23.9%)
$64.63 M(-12.5%)
Sep 2008
-
$15.29 M(-18.1%)
$73.83 M(+3.5%)
DateAnnualQuarterlyTTM
Jun 2008
-
$18.66 M(-2.0%)
$71.36 M(+0.7%)
Mar 2008
-
$19.04 M(-8.6%)
$70.87 M(+6.0%)
Dec 2007
$66.89 M(-4.0%)
$20.84 M(+62.7%)
$66.89 M(+1.5%)
Sep 2007
-
$12.81 M(-29.5%)
$65.90 M(-6.1%)
Jun 2007
-
$18.18 M(+20.7%)
$70.15 M(+3.3%)
Mar 2007
-
$15.06 M(-24.1%)
$67.88 M(-2.6%)
Dec 2006
$69.70 M(+12.5%)
$19.85 M(+16.3%)
$69.70 M(+1.3%)
Sep 2006
-
$17.07 M(+7.3%)
$68.81 M(+8.5%)
Jun 2006
-
$15.91 M(-5.8%)
$63.40 M(+2.2%)
Mar 2006
-
$16.88 M(-11.0%)
$62.03 M(+0.1%)
Dec 2005
$61.98 M(+2.2%)
$18.96 M(+62.7%)
$61.98 M(-0.2%)
Sep 2005
-
$11.65 M(-19.8%)
$62.09 M(-1.0%)
Jun 2005
-
$14.53 M(-13.7%)
$62.75 M(-0.3%)
Mar 2005
-
$16.83 M(-11.7%)
$62.95 M(+3.8%)
Dec 2004
$60.65 M(+24.3%)
$19.07 M(+54.9%)
$60.65 M(+5.8%)
Sep 2004
-
$12.31 M(-16.5%)
$57.32 M(-2.0%)
Jun 2004
-
$14.74 M(+1.4%)
$58.46 M(+8.1%)
Mar 2004
-
$14.53 M(-7.7%)
$54.10 M(+10.9%)
Dec 2003
$48.78 M(+79.0%)
$15.74 M(+17.0%)
$48.78 M(+18.5%)
Sep 2003
-
$13.45 M(+29.7%)
$41.16 M(+19.1%)
Jun 2003
-
$10.38 M(+12.6%)
$34.57 M(+10.3%)
Mar 2003
-
$9.21 M(+13.4%)
$31.36 M(+14.6%)
Dec 2002
$27.26 M(+64.7%)
$8.12 M(+18.4%)
$27.37 M(+15.5%)
Sep 2002
-
$6.86 M(-4.2%)
$23.70 M(+10.1%)
Jun 2002
-
$7.16 M(+36.9%)
$21.52 M(+15.1%)
Mar 2002
-
$5.23 M(+17.5%)
$18.69 M(+13.0%)
Dec 2001
$16.55 M(+71.3%)
$4.45 M(-4.8%)
$16.55 M(+4.9%)
Sep 2001
-
$4.68 M(+7.9%)
$15.78 M(+18.7%)
Jun 2001
-
$4.34 M(+40.6%)
$13.29 M(+18.5%)
Mar 2001
-
$3.08 M(-16.3%)
$11.21 M(+16.1%)
Dec 2000
$9.66 M(+37.9%)
$3.68 M(+68.4%)
$9.66 M(+24.3%)
Sep 2000
-
$2.19 M(-3.2%)
$7.77 M(+2.3%)
Jun 2000
-
$2.26 M(+47.9%)
$7.60 M(+12.6%)
Mar 2000
-
$1.53 M(-15.1%)
$6.75 M(-3.9%)
Dec 1999
$7.00 M(+367.0%)
$1.80 M(-10.6%)
$7.02 M(+14.7%)
Sep 1999
-
$2.01 M(+43.1%)
$6.12 M(+45.5%)
Jun 1999
-
$1.41 M(-21.9%)
$4.21 M(+40.2%)
Mar 1999
-
$1.80 M(+100.0%)
$3.00 M(+100.0%)
Dec 1998
$1.50 M(-16.7%)
$900.00 K(+800.0%)
$1.50 M(+25.0%)
Sep 1998
-
$100.00 K(-50.0%)
$1.20 M(-29.4%)
Jun 1998
-
$200.00 K(-33.3%)
$1.70 M(-10.5%)
Mar 1998
-
$300.00 K(-50.0%)
$1.90 M(+11.8%)
Dec 1997
$1.80 M(+157.1%)
$600.00 K(0.0%)
$1.70 M(+21.4%)
Sep 1997
-
$600.00 K(+50.0%)
$1.40 M(+55.6%)
Jun 1997
-
$400.00 K(+300.0%)
$900.00 K(+28.6%)
Mar 1997
-
$100.00 K(-66.7%)
$700.00 K(0.0%)
Dec 1996
$700.00 K(-41.7%)
$300.00 K(+200.0%)
$700.00 K(+16.7%)
Sep 1996
-
$100.00 K(-50.0%)
$600.00 K(-33.3%)
Jun 1996
-
$200.00 K(+100.0%)
$900.00 K(-18.2%)
Mar 1996
-
$100.00 K(-50.0%)
$1.10 M(-8.3%)
Dec 1995
$1.20 M(+9.1%)
$200.00 K(-50.0%)
$1.20 M(+9.1%)
Sep 1995
-
$400.00 K(0.0%)
$1.10 M(+22.2%)
Jun 1995
-
$400.00 K(+100.0%)
$900.00 K(-25.0%)
Mar 1995
-
$200.00 K(+100.0%)
$1.20 M(0.0%)
Dec 1994
$1.10 M(-54.2%)
$100.00 K(-50.0%)
$1.20 M(-36.8%)
Sep 1994
-
$200.00 K(-71.4%)
$1.90 M(-9.5%)
Jun 1994
-
$700.00 K(+250.0%)
$2.10 M(+5.0%)
Mar 1994
-
$200.00 K(-75.0%)
$2.00 M(-16.7%)
Dec 1993
$2.40 M(-56.4%)
$800.00 K(+100.0%)
$2.40 M(-22.6%)
Sep 1993
-
$400.00 K(-33.3%)
$3.10 M(-20.5%)
Jun 1993
-
$600.00 K(0.0%)
$3.90 M(-22.0%)
Mar 1993
-
$600.00 K(-60.0%)
$5.00 M(-13.8%)
Dec 1992
$5.50 M
$1.50 M(+25.0%)
$5.80 M(+34.9%)
Sep 1992
-
$1.20 M(-29.4%)
$4.30 M(+38.7%)
Jun 1992
-
$1.70 M(+21.4%)
$3.10 M(+121.4%)
Mar 1992
-
$1.40 M
$1.40 M

FAQ

  • What is BIOLASE annual revenue?
  • What is the all time high annual revenue for BIOLASE?
  • What is BIOLASE annual revenue year-on-year change?
  • What is BIOLASE quarterly revenue?
  • What is the all time high quarterly revenue for BIOLASE?
  • What is BIOLASE quarterly revenue year-on-year change?
  • What is BIOLASE TTM revenue?
  • What is the all time high TTM revenue for BIOLASE?
  • What is BIOLASE TTM revenue year-on-year change?

What is BIOLASE annual revenue?

The current annual revenue of BIOL is $49.16 M

What is the all time high annual revenue for BIOLASE?

BIOLASE all-time high annual revenue is $69.70 M

What is BIOLASE annual revenue year-on-year change?

Over the past year, BIOL annual revenue has changed by +$702.00 K (+1.45%)

What is BIOLASE quarterly revenue?

The current quarterly revenue of BIOL is $10.85 M

What is the all time high quarterly revenue for BIOLASE?

BIOLASE all-time high quarterly revenue is $20.84 M

What is BIOLASE quarterly revenue year-on-year change?

Over the past year, BIOL quarterly revenue has changed by -$71.00 K (-0.65%)

What is BIOLASE TTM revenue?

The current TTM revenue of BIOL is $46.03 M

What is the all time high TTM revenue for BIOLASE?

BIOLASE all-time high TTM revenue is $73.83 M

What is BIOLASE TTM revenue year-on-year change?

Over the past year, BIOL TTM revenue has changed by -$3.70 M (-7.44%)